We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+13.44%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$500M
AUM Growth
+$39.5M
Cap. Flow
-$1.25M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.84%
Holding
1,111
New
66
Increased
187
Reduced
301
Closed
121

Top Buys

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$1.88M
2
IBIT icon
iShares Bitcoin Trust
IBIT
+$1.45M
3
ETHA
iShares Ethereum Trust ETF
ETHA
+$606K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$330K
5
GRNY
FundStrat Granny Shots US Large Cap ETF
GRNY
+$324K

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$2.11M
2
AAPL icon
Apple
AAPL
+$847K
3
XLG icon
Invesco S&P 500 Top 50 ETF
XLG
+$325K
4
RDVI icon
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
+$285K
5
MSFT icon
Microsoft
MSFT
+$235K

Sector Composition

Rank Sector Weight
1 Technology 27.84%
2 Financials 15.73%
3 Industrials 12.04%
4 Real Estate 10.42%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AJG icon
551
Arthur J. Gallagher & Co
AJG
$64.7B
$17.9K ﹤0.01%
56
– –
NVG icon
552
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
$17.9K ﹤0.01%
1,497
– –
CAG icon
553
Conagra Brands
CAG
$7.07B
$17.8K ﹤0.01%
868
– –
VCEL icon
554
Vericel Corp
VCEL
$2.25B
$17.7K ﹤0.01%
+415
New +$17.3K
PR
555
Permian Resources
PR
$17.8B
$17.5K ﹤0.01%
1,283
– –
ANIP icon
556
ANI Pharmaceuticals
ANIP
$1.72B
$17.4K ﹤0.01%
267
– –
BLV icon
557
Vanguard Long-Term Bond ETF
BLV
$5.69B
$17.3K ﹤0.01%
249
+3
+1% +$205
XGN icon
558
Exagen
XGN
$161M
$17.2K ﹤0.01%
+2,471
New +$15K
FTV icon
559
Fortive
FTV
$18.6B
$17.1K ﹤0.01%
328
-107
-25% -$5.6K
LH icon
560
Labcorp
LH
$26.1B
$17.1K ﹤0.01%
+65
New +$15.8K
CPRT icon
561
Copart
CPRT
$27.4B
$17K ﹤0.01%
347
– –
MHH icon
562
Mastech Digital
MHH
$92.7M
$17K ﹤0.01%
2,374
-174
-7% -$1.31K
ETON icon
563
Eton Pharmaceutcials
ETON
$1.2B
$16.9K ﹤0.01%
1,183
– –
SWTX
564
DELISTED
SpringWorks Therapeutics
SWTX
$16.7K ﹤0.01%
+356
New +$15.8K
DBVT
565
DBV Technologies
DBVT
$897M
$16.7K ﹤0.01%
+1,822
New +$16.1K
ZTS icon
566
Zoetis
ZTS
$30.9B
$16.7K ﹤0.01%
107
– –
XERS icon
567
Xeris Biopharma Holdings
XERS
$1.46B
$16.7K ﹤0.01%
+3,573
New +$16.4K
ROIV icon
568
Roivant Sciences
ROIV
$25.8B
$16.6K ﹤0.01%
+1,474
New +$16K
TGTX icon
569
TG Therapeutics
TGTX
$7.52B
$16.6K ﹤0.01%
+460
New +$17.1K
BRO icon
570
Brown & Brown
BRO
$24B
$16.5K ﹤0.01%
149
– –
TAP icon
571
Molson Coors Class B
TAP
$7.93B
$16.5K ﹤0.01%
343
-197
-36% -$10.8K
RIGL icon
572
Rigel Pharmaceuticals
RIGL
$778M
$16.4K ﹤0.01%
+877
New +$16.6K
IFF icon
573
International Flavors & Fragrances
IFF
$21.7B
$16.3K ﹤0.01%
222
– –
EMLP icon
574
First Trust North American Energy Infrastructure Fund
EMLP
$4.1B
$16.3K ﹤0.01%
435
+135
+45% +$4.94K
ARQT icon
575
Arcutis Biotherapeutics
ARQT
$3.26B
$16.2K ﹤0.01%
+1,154
New +$16.2K
21 22
23
24 25

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Truvestments Capital held 1,111 positions worth $500M, up 8.6% from $461M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital's Q2 2025 filing shows 66 new, 187 increased, 301 reduced and 121 closed positions. Its largest new stake was FundStrat Granny Shots US Large Cap ETF: 16,250 shares worth $369K. The largest sale was Wells Fargo, an estimated $2.11M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

  • Truvestments Capital's largest Q2 2025 buy was FundStrat Granny Shots US Large Cap ETF: 16,250 shares worth $369K.
  • Truvestments Capital added most to Strategy Inc in Q2 2025, an estimated $1.88M increase.
  • Truvestments Capital's biggest Q2 2025 reduction was Wells Fargo, cutting an estimated $2.11M.
  • Truvestments Capital fully exited Patterson Companies, Inc. in Q2 2025, selling an estimated $141K.
  • Truvestments Capital's ten largest holdings make up 27% of its $500M portfolio in Q2 2025.
  • Truvestments Capital opened 66 new positions and closed 121 in Q2 2025.
  • Truvestments Capital's portfolio value rose 8.6% quarter-over-quarter to $500M.

Based on Truvestments Capital's 13F filing for Q2 2025, filed 13 Aug 2025.